Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1133416 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $3.49Day +2.95%Mkt cap $230M1Y +5.8%Off 52W high −51.1%Vol (1Y) 94.7%
Daily closing price, split-adjusted to the current basis; 3y shown of 5,293 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest12.9% of sh out |
| Days to cover11.3d |
| 13F net flow (QoQ)+3.23% |
| Top-10 13F concentration62.2% |
| Next report (est.)2026-08-14 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$26.3M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−16.1% |
| 1Y+5.8% |
| 3Y+132.7% |
| 5Y+33.2% |
| 10Y+112.8% |
| Since incept. (ann.)−7.1% |
Total return through 2026-07-29 · series begins 2005-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)94.7% |
| Ann. volatility (3Y)97.1% |
| Sharpe (1Y)0.61 |
| Sharpe (3Y)0.78 |
| Max drawdown (1Y)−68.0% |
| Max drawdown (3Y)−80.0% |
| Beta (3Y vs SPY)0.03 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $5M | 2.99% | new |
| MARSHALL WACE, LLP | 1.2M | $3M | 1.85% | +102.6% |
| OSAIC HOLDINGS, INC. | 1.1M | $3M | 1.70% | +2.9% |
| BlackRock, Inc. | 799,237 | $2M | 1.21% | +0.3% |
| MILLENNIUM MANAGEMENT LLC | 798,434 | $2M | 1.21% | +239.0% |
| Wealthspire Advisors, LLC | 721,788 | $2M | 1.10% | +19.9% |
| GEODE CAPITAL MANAGEMENT, LLC | 612,786 | $2M | 0.93% | +2.5% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 555,702 | $2M | 0.84% | +93.7% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | −$0.08 | — | — | — |
| 2025-09-30 | 2025-11-14 | −$0.13 | — | — | — |
| 2025-06-30 | 2025-08-14 | −$0.12 | — | — | — |
| 2025-03-31 | 2025-05-15 | −$0.15 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-14 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
